Free tool
Oncology stocks
We cover 113 companies grouped under the Oncology theme. The median market value in the group is $25.34M. Across the group, the median move over the past trading day is 0.00%. 24% of the 110 with a 200-day average trade above it. Price change over the past year runs from −81.9% to +17.6% across the middle 80 percent of the group, with a median of −41.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
113 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| JATT | JATT II Acquisition Corp. | $12.46 | +11.80% | +18.62% | +18.62% |
| 4575.T | CanBas Co., Ltd. | 821.00 JPY | +12.47% | +0.24% | −40.51% |
| ACRV | Acrivon Therapeutics, Inc. | $2.18 | +39.74% | −11.38% | +63.91% |
| 4579.T | RaQualia Pharma Inc. | 571.00 JPY | +26.05% | −41.26% | +4.58% |
| OSE.PA | OSE Immunotherapeutics SA | 3.19 EUR | +0.69% | −39.85% | −47.82% |
| MAIA | MAIA Biotechnology, Inc. | $1.41 | +10.16% | −11.88% | −10.76% |
| CTOR | Citius Oncology, Inc. | $0.81 | +45.70% | −24.99% | −57.14% |
| 0QW5.L | Heidelberg Pharma AG | 2.46 EUR | +3.36% | −2.38% | −45.58% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.94 | −7.66% | −40.48% | −17.53% |
| 0J4V.L | Heron Therapeutics, Inc. | $0.32 | +1.38% | −74.92% | −76.73% |
| POLB.L | Poolbeg Pharma PLC | 8.50 GBP | +38.21% | +117.95% | +161.54% |
| 4888.T | Stella Pharma Corporation | 364.00 JPY | +17.42% | +71.70% | −9.23% |
| CRDF | Cardiff Oncology, Inc. | $1.02 | +21.43% | −61.65% | −53.85% |
| ELTX | Elicio Therapeutics, Inc. | $3.01 | +0.33% | −62.61% | −72.71% |
| OSTX | OS Therapies Incorporated | $1.65 | +7.84% | +23.13% | −24.66% |
| PLRX | Pliant Therapeutics, Inc. | $1.14 | +5.56% | −8.80% | −23.49% |
| XBIT | XBiotech Inc. | $2.30 | +1.77% | −3.36% | −28.13% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +10.59% | +6.10% | −8.10% |
| BOLD | Boundless Bio, Inc. | $2.94 | +18.55% | +140.98% | +160.18% |
| MAAT.PA | MaaT Pharma SA | 3.05 EUR | +8.75% | −45.43% | −39.58% |
| RNXT | RenovoRx, Inc. | $1.42 | +47.15% | +70.06% | +58.13% |
| HRTX | Heron Therapeutics, Inc. | $0.32 | −29.76% | −74.36% | −76.59% |
| XLO | Xilio Therapeutics, Inc. | $9.08 | −0.11% | −3.49% | −7.35% |
| IMM.AX | Immutep Limited | 0.05 AUD | +14.89% | −87.44% | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +13.08% | −13.53% | −13.53% |
| IMMP | Immutep Limited | $0.38 | +0.50% | −87.05% | −77.54% |
| 0OCQ.L | Transgene SA | 0.81 EUR | −0.25% | −16.36% | −18.38% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −5.00% | −20.83% | −26.92% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| 0RAD.L | OSE Immunotherapeutics SA | 3.16 EUR | −2.11% | −40.40% | −48.92% |
| TIL | Instil Bio, Inc. | $7.81 | +9.23% | −30.70% | −69.62% |
| 4597.T | Solasia Pharma K.K. | 29.00 JPY | 0.00% | +3.57% | −23.68% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −15.00% | −18.07% | +58.14% |
| CANTA.ST | Cantargia AB (publ) | 1.90 SEK | +1.71% | −53.86% | −28.93% |
| IBO | Impact BioMedical Inc. | $0.46 | +6.53% | −11.33% | −20.79% |
| BKHA | Black Hawk Acquisition Corporation | $11.89 | −1.74% | +5.69% | +8.09% |
| SVE.WA | Synthaverse S.A. | 3.04 PLN | +10.55% | −20.73% | −37.70% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +12.77% | +8.16% | −33.75% |
| MOC.WA | Molecure S.A. | 6.14 PLN | +2.33% | −6.40% | −21.18% |
| CNTX | Context Therapeutics Inc. | $0.44 | −30.00% | −71.91% | −50.13% |
| 206A.T | PRISM BioLab Co.,LTD | 171.00 JPY | +16.33% | +6.21% | −6.56% |
| SNT.AX | Syntara Limited | 0.03 AUD | +18.18% | −23.53% | −1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | 75.00 JPY | 0.00% | −33.04% | −58.56% |
| ATNM | Actinium Pharmaceuticals, Inc. | $1.08 | +26.46% | −21.17% | −39.66% |
| BCTX | BriaCell Therapeutics Corp. | $3.77 | +6.20% | −47.42% | −49.67% |
| BCT.TO | BriaCell Therapeutics Corp. | 5.14 CAD | +1.98% | −47.66% | −50.62% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −7.35% | −30.00% | −58.28% |
| BYSI | BeyondSpring Inc. | $0.72 | −38.44% | −55.27% | −60.43% |
| MDNA.TO | Medicenna Therapeutics Corp. | 0.47 CAD | +36.23% | −53.00% | −58.77% |
| EVAX | Evaxion A/S | $3.35 | +15.92% | −28.87% | +4.49% |
| LTRN | Lantern Pharma Inc. | $2.18 | −21.86% | −29.90% | −52.30% |
| NNG.WA | NanoGroup S.A. | 2.47 PLN | +2.28% | −7.84% | −14.09% |
| NXTC | NextCure, Inc. | $5.91 | +15.43% | −55.50% | +13.33% |
| PSTV | Plus Therapeutics Inc | $3.84 | +2.90% | −72.59% | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $2.68 | +13.56% | −71.64% | −76.49% |
| CVM | CEL-SCI Corporation | $1.48 | +25.42% | −71.26% | −85.98% |
| MRKR | Marker Therapeutics, Inc. | $1.52 | +24.59% | −1.30% | +20.63% |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +4.96% | −26.80% | −45.96% |
| CCM | Concord Medical Services Holdings Limited | $4.95 | +9.76% | +15.93% | −10.65% |
| ABVC | ABVC BioPharma, Inc. | $0.80 | −21.58% | −63.47% | −72.70% |
| ALLR | Allarity Therapeutics, Inc. | $1.33 | +8.13% | +16.67% | +41.34% |
| NOX.AX | Noxopharm Limited | 0.09 AUD | −8.00% | −2.13% | −20.00% |
| DEX.ST | DexTech Medical AB | 10.40 SEK | −0.95% | +12.43% | +20.93% |
| TPST | Tempest Therapeutics, Inc. | $1.11 | +18.72% | −62.37% | −89.50% |
| B8FK.DE | Biofrontera AG | 2.52 EUR | −1.95% | −1.18% | −4.55% |
| ABERA.ST | Abera Bioscience AB | 8.14 SEK | −7.29% | +13.06% | −0.12% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +2.76% | −34.65% | −56.43% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −33.33% | −60.00% | −62.96% |
| CTXR | Citius Pharmaceuticals, Inc. | $0.60 | +16.77% | −28.81% | −52.09% |
| MDCX | Medicus Pharma Ltd. | $0.26 | −17.92% | −83.69% | −87.97% |
| INTS | Intensity Therapeutics, Inc. | $4.90 | +7.11% | −51.89% | −37.24% |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +20.83% | −11.22% | −31.23% |
| ACTI.ST | Active Biotech AB (publ) | 5.55 SEK | +7.77% | +20.65% | −60.62% |
| AKTX | Akari Therapeutics, Plc | $7.87 | −6.97% | −32.16% | −77.77% |
| PHIO | Phio Pharmaceuticals Corp. | $1.17 | +11.43% | +7.34% | −41.21% |
| GTBP | GT Biopharma, Inc. | $0.30 | −10.27% | −63.32% | −72.50% |
| BLRX | BioLineRx Ltd. | $2.85 | +1.06% | +1.79% | −25.97% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +11.95% | −9.58% | −45.33% |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.35% | −71.71% | −87.99% |
| PUR.WA | MultiQure S.A. | 3.14 PLN | +45.81% | −23.35% | −53.66% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +5.05% | −80.92% | −81.94% |
| IMNN | Imunon, Inc. | $1.66 | +8.50% | −57.97% | −73.86% |
| CNSP | CNS Pharmaceuticals, Inc. | $5.80 | +14.40% | +9.43% | −11.31% |
| AIM | AIM ImmunoTech Inc. | $0.25 | +1.60% | −77.99% | −89.97% |
| PAB.AX | Patrys Limited | 0.03 AUD | −22.50% | +14.81% | −11.43% |
| BOLT | Bolt Biotherapeutics, Inc. | $3.85 | −3.12% | −33.51% | −29.28% |
| CANF | Can-Fite BioPharma Ltd. | $3.32 | +5.40% | −24.55% | −74.46% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | 0.32 EUR | +1.26% | −17.65% | −17.01% |
| CHOSA.ST | CHOSA Oncology AB | 0.73 SEK | −14.59% | −20.22% | −12.00% |
| ITOC | iTonic Holdings Ltd. | $0.27 | +9.68% | −37.07% | −51.75% |
| LIMN | Liminatus Pharma, Inc. | $4.61 | +4375.73% | +619.19% | +35.59% |
| NCNA | NuCana plc | $1.47 | +16.67% | −59.62% | −56.76% |
| PCSA | Processa Pharmaceuticals, Inc. | $2.18 | −15.83% | −25.60% | −60.36% |
| KAPA | Kairos Pharma, Ltd. | $0.25 | −19.94% | −65.95% | −79.82% |
| 0GP7.L | Medivir AB (publ) | 2.08 SEK | +9.14% | +355.54% | +3.85% |
| NFX.L | Nuformix plc | 0.17 GBP | +3.13% | −44.07% | +106.25% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +25.00% | −47.37% | −54.55% |
| BCAB | BioAtla, Inc. | $3.26 | −4.12% | −87.79% | −81.69% |
| HCWB | HCW Biologics Inc. | $2.60 | −1.89% | +132.14% | −53.15% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +37.14% |
| OSRH | OSR Health, Inc. | $0.12 | −73.09% | −80.22% | −88.47% |
| DBP-B.ST | Double Bond Pharmaceutical Int. | 0.15 SEK | +18.62% | +9.33% | +9.33% |
| RDHL | RedHill Biopharma Ltd. | $0.61 | −13.56% | −41.25% | −55.83% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.31 | −25.57% | +11.02% | −16.03% |
| GOVX | GeoVax Labs, Inc. | $0.64 | −15.54% | −87.60% | −96.61% |
| ARTL | Artelo Biosciences, Inc. | $0.72 | −28.99% | −81.18% | −97.47% |
| IVX.AX | Invion Limited | 0.04 AUD | −15.22% | −58.06% | −70.00% |
| VAL.L | ValiRx plc | 0.16 GBP | −3.13% | −57.53% | −73.04% |
| NXTS | Nexentis Technologies Inc. | $1.85 | +10.78% | −83.38% | −96.64% |
| PPBT | Purple Biotech Ltd | $1.65 | +14.58% | −75.00% | −92.53% |
| PPCB | Propanc Biopharma, Inc. | $1.13 | −14.39% | −92.09% | −98.66% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
| PTP.DE | Pentixapharm Holding AG N | 1.88 EUR | −4.57% | +22.08% | +8.55% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.